Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy

CARSTEN NIEDER, BARD MANNSÅKER and ROSALBA YOBUTA
Anticancer Research March 2022, 42 (3) 1477-1480; DOI: https://doi.org/10.21873/anticanres.15618
CARSTEN NIEDER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carsten.nieder{at}nlsh.no
BARD MANNSÅKER
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROSALBA YOBUTA
1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 3 1477-1480
DOI 
https://doi.org/10.21873/anticanres.15618
PMID 
35220241

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 19, 2021
  • Revision received January 12, 2022
  • Accepted January 13, 2022
  • Published online February 26, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. CARSTEN NIEDER1,2⇑,
  2. BARD MANNSÅKER1 and
  3. ROSALBA YOBUTA1
  1. 1Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway;
  2. 2Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
  1. Correspondence to: Carsten Nieder, Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway. Tel: +47 75578449, Fax: +47 75534975, e-mail: carsten.nieder{at}nlsh.no
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 42, Issue 3
March 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy
CARSTEN NIEDER, BARD MANNSÅKER, ROSALBA YOBUTA
Anticancer Research Mar 2022, 42 (3) 1477-1480; DOI: 10.21873/anticanres.15618

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Independent External Validation of the METSSS Model Predicting Survival After Palliative Radiotherapy
CARSTEN NIEDER, BARD MANNSÅKER, ROSALBA YOBUTA
Anticancer Research Mar 2022, 42 (3) 1477-1480; DOI: 10.21873/anticanres.15618
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Independent Validation of a Risk Stratification Model Predicting Survival in Elderly Patients Irradiated for Bone Metastases
  • Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer
  • Google Scholar

More in this TOC Section

  • Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
  • Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases
  • Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
Show more Clinical Studies

Keywords

  • Palliative radiation therapy
  • radiotherapy
  • bone metastases
  • brain metastases
  • Prognostic model
  • comorbidity
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire